CRISPR Therapeutics AG
CRSP · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $298,257 | $389,477 | $211,885 | $923,031 |
| Short-Term Investments | $1,605,569 | $1,304,215 | $1,603,433 | $1,456,098 |
| Receivables | $25,000 | $200,000 | $0 | $305 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $8,306 | $14,386 | $37,708 | $38,079 |
| Total Curr. Assets | $1,937,132 | $1,908,078 | $1,853,026 | $2,417,513 |
| Property Plant & Equip (Net) | $277,554 | $305,938 | $320,555 | $312,035 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $16 | $71 | $125 |
| Long-Term Investments | $0 | $1,973 | $53,130 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $27,348 | $13,566 | $16,275 | $22,204 |
| Total NC Assets | $304,902 | $321,493 | $390,031 | $334,364 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $2,242,034 | $2,229,571 | $2,243,057 | $2,751,877 |
| Liabilities | – | – | – | – |
| Payables | $14,709 | $38,147 | $27,428 | $14,816 |
| Short-Term Debt | $17,288 | $15,625 | $15,842 | $12,158 |
| Tax Payable | $451 | $0 | $0 | $0 |
| Deferred Revenue | $3,845 | $4,105 | $0 | $1,011 |
| Other Curr. Liab. | $51,489 | $50,914 | $77,837 | $91,898 |
| Total Curr. Liab. | $87,782 | $108,791 | $121,107 | $119,883 |
| LT Debt | $206,405 | $223,007 | $228,179 | $212,872 |
| Deferred Rev, NC | $12,323 | $14,012 | $12,323 | $12,323 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $3,444 | $958 | $5,969 | $7,339 |
| Total NC Liab. | $222,172 | $237,977 | $246,471 | $232,534 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $206,405 | $223,007 | $228,179 | $212,872 |
| Total Liabilities | $309,954 | $346,768 | $367,578 | $352,417 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $2,698 | $2,497 | $2,441 | $2,391 |
| Retained Earnings | -$1,365,952 | -$999,700 | -$846,090 | -$195,915 |
| AOCI | $1,840 | $1,913 | -$15,647 | -$5,067 |
| Other Equity | $3,293,494 | $2,878,093 | $2,734,775 | $2,598,051 |
| Total Equity | $1,932,080 | $1,882,803 | $1,875,479 | $2,399,460 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $2,242,034 | $2,229,571 | $2,243,057 | $2,751,877 |
| Net Debt | -$74,564 | -$150,845 | $32,136 | -$698,001 |